Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

Christopher Skedgel; Daniel Rayson; Tallal Younis

doi:10.1007/s00520-015-2805-7

Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?

Christopher Skedgel
, Daniel Rayson
, Tallal Younis

Research output: Contribution to journal › Article › peer-review

9 Citations (Scopus)

19 Downloads (Pure)

Original language	English
Pages (from-to)	387-394
Number of pages	8
Journal	Journal of Supportive Care in Cancer
Volume	24
Issue number	1
Early online date	17 Jun 2015
DOIs	https://doi.org/10.1007/s00520-015-2805-7
Publication status	Published - Jan 2016

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Access to Document

10.1007/s00520-015-2805-7

G-CSFmanuscript20150521b.docAccepted author manuscript, 364 KB

Cite this

@article{011f49e047a04b368de9e2c3c36b9a2b,

title = "Is febrile neutropenia prophylaxis with granulocyte-colony stimulating factors economically justified for adjuvant TC chemotherapy in breast cancer?",

author = "Christopher Skedgel and Daniel Rayson and Tallal Younis",

year = "2016",

month = jan,

doi = "10.1007/s00520-015-2805-7",

language = "English",

volume = "24",

pages = "387--394",

journal = "Journal of Supportive Care in Cancer",

issn = "0941-4355",